Wang Xiaodonginsider trades
In SEC Form 4 filings, Wang Xiaodong is listed as Director of BeOne Medicines Ltd. (ONC). In the last 90 days, Wang Xiaodong sold $35.57M of BeOne Medicines Ltd. (ONC) on the open market and bought none. All 23 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| ONCBeOne Medicines Ltd. | Director | 29 | Oct 15 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-10
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| ONCBeOne Medicines Ltd. | Oct 13 | Oct 15 | M | 31,027 | $36.90 | $1,144,896 | 31,027 | Yes | Form 4 |
| ONCBeOne Medicines Ltd. | Oct 13 | Oct 15 | S | 7,167 | $349.56 | Sale −$2,505,306 | 23,860 | Yes | Form 4 |
| ONCBeOne Medicines Ltd. | Oct 13 | Oct 15 | S | 10,361 | $350.47 | Sale −$3,631,262 | 13,499 | Yes | Form 4 |
| ONCBeOne Medicines Ltd. | Oct 13 | Oct 15 | S | 5,681 | $351.40 | Sale −$1,996,280 | 7,818 | Yes | Form 4 |
| ONCBeOne Medicines Ltd. | Oct 13 | Oct 15 | S | 6,558 | $352.57 | Sale −$2,312,148 | 1,260 | Yes | Form 4 |
| ONCBeOne Medicines Ltd. | Oct 13 | Oct 15 | S | 1,260 | $353.24 | Sale −$445,078 | not reported | Yes | Form 4 |
| ONCBeOne Medicines Ltd. | Oct 13 | Oct 15 | M · derivative | 403,351 | $2.84 | $1,145,517 | 403,364 | Yes | Form 4 |
| ONCBeOne Medicines Ltd. | Sep 28 | Sep 30 | M | 31,028 | $36.90 | $1,144,933 | 31,028 | Yes | Form 4 |
| ONCBeOne Medicines Ltd. | Sep 28 | Sep 30 | S | 160 | $356.97 | Sale −$57,115 | 30,868 | Yes | Form 4 |
| ONCBeOne Medicines Ltd. | Sep 28 | Sep 30 | S | 120 | $358.71 | Sale −$43,045 | 30,748 | Yes | Form 4 |
| ONCBeOne Medicines Ltd. | Sep 28 | Sep 30 | S | 40 | $359.16 | Sale −$14,366 | 30,708 | Yes | Form 4 |
| ONCBeOne Medicines Ltd. | Sep 28 | Sep 30 | S | 2,241 | $361.05 | Sale −$809,120 | 28,467 | Yes | Form 4 |
| ONCBeOne Medicines Ltd. | Sep 28 | Sep 30 | S | 4,239 | $362.17 | Sale −$1,535,228 | 24,228 | Yes | Form 4 |
| ONCBeOne Medicines Ltd. | Sep 28 | Sep 30 | S | 3,499 | $363.10 | Sale −$1,270,485 | 20,729 | Yes | Form 4 |
| ONCBeOne Medicines Ltd. | Sep 28 | Sep 30 | S | 3,419 | $364.07 | Sale −$1,244,747 | 17,310 | Yes | Form 4 |
| ONCBeOne Medicines Ltd. | Sep 28 | Sep 30 | S | 2,047 | $365.85 | Sale −$748,891 | 15,263 | Yes | Form 4 |
| ONCBeOne Medicines Ltd. | Sep 28 | Sep 30 | S | 14,525 | $366.58 | Sale −$5,324,550 | 738 | Yes | Form 4 |
| ONCBeOne Medicines Ltd. | Sep 28 | Sep 30 | S | 738 | $367.23 | Sale −$271,012 | not reported | Yes | Form 4 |
| ONCBeOne Medicines Ltd. | Sep 28 | Sep 30 | M · derivative | 403,364 | $2.84 | $1,145,554 | 806,715 | Yes | Form 4 |
| ONCBeOne Medicines Ltd. | Sep 8 | Sep 10 | S | 1,181 | $345.38 | Sale −$407,897 | 6,079 | Yes | Form 4 |
| ONCBeOne Medicines Ltd. | Sep 8 | Sep 10 | S | 2,841 | $346.16 | Sale −$983,433 | 3,238 | Yes | Form 4 |
| ONCBeOne Medicines Ltd. | Sep 8 | Sep 10 | S | 1,517 | $347.39 | Sale −$526,993 | 1,721 | Yes | Form 4 |
| ONCBeOne Medicines Ltd. | Sep 8 | Sep 10 | S | 1,721 | $348.01 | Sale −$598,930 | not reported | Yes | Form 4 |
| ONCBeOne Medicines Ltd. | Sep 8 | Sep 10 | M | 31,027 | $36.90 | $1,144,896 | 31,027 | Yes | Form 4 |
| ONCBeOne Medicines Ltd. | Sep 8 | Sep 10 | S | 7,492 | $348.31 | Sale −$2,609,573 | 23,535 | Yes | Form 4 |
| ONCBeOne Medicines Ltd. | Sep 8 | Sep 10 | S | 10,688 | $349.28 | Sale −$3,733,141 | 12,847 | Yes | Form 4 |
| ONCBeOne Medicines Ltd. | Sep 8 | Sep 10 | S | 6,569 | $350.27 | Sale −$2,300,951 | 6,278 | Yes | Form 4 |
| ONCBeOne Medicines Ltd. | Sep 8 | Sep 10 | S | 6,278 | $351.25 | Sale −$2,205,174 | not reported | Yes | Form 4 |
| ONCBeOne Medicines Ltd. | Sep 8 | Sep 10 | M · derivative | 403,351 | $2.84 | $1,145,517 | 1,210,079 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.